SCHEMBL3877397

SCHEMBL3877397

CCCc1cc2c(O)c(c1)Cc1cc(CCC)cc(c1OC)Cc1cc(CCC)cc(c1OC)Cc1cc(CCC)cc(c1OC)C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 4/20 0.40
TNKS2 Q9H2K2 1/20 0.37
PTPN2 P17706 4/20 0.36
PTPN1 P18031 4/20 0.36
PTPN11 Q06124 4/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
PTPN4 P29074 1/20 0.36
PTPN9 P43378 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
GABRB2 P47870 1/20 0.36
HMGCR P04035 1/20 0.36
PTGS2 P35354 1/20 0.36
ALOX5 P09917 4/20 0.36
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3875014 0.87 PTPRB (0.48) PTPRBPTPN2PTPN1PTPN11ALDH1A1
SCHEMBL3873166 0.81 TLR4 (0.40) PTPRBTNKS2PTPN2PTPN1PTPN11
SCHEMBL13686090 0.79 TLR4 (0.38) PTPRBPTPN2PTPN1PTPN11ALDH1A1
SCHEMBL15867520 0.74 PTGS2 (0.37) PTPRBPTPN2PTPN1PTPN11ALDH1A1
SCHEMBL18126784 0.74 TDP1 (0.54) GABRA1GABRB2HMGCRPTGS2ALOX5
SCHEMBL15867509 0.70 PTPRC (0.36) PTPRBPTPN2PTPN1PTPN11ALDH1A1
SCHEMBL12549814 0.70 CD69 (0.46) PTPRBPTPN2PTPN1PTPN11GABRA1
SCHEMBL15867518 0.70 PTPRC (0.36) PTPRBPTPN2PTPN1PTPN11ALDH1A1
SCHEMBL6395446 0.70 MAPT (0.39) CYP3A4PTGS2DRD2
SCHEMBL223826 0.70 AKR1B1 (0.59) TNKS2ALDH1A1CYP3A4GABRA1GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585928-B2 monomers of acetylenic homo- or copolymers; cured polymers has low dielectric constant as insulating layers in microelectronic devices DOW GLOBAL TECHNOLOGIES (US) 2009-09-08 US disclosed
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom DOW GLOBAL TECHNOLOGIES LLC 2007-02-01 US disclosed
WO-2005042613-A1 MULTIFUNCTIONAL MONOMERS CONTAINING BOUND MESOGENIC PORAGEN FORMING MOIETIES AND POLYARYLENE COMPOSITIONS THEREFROM DOW GLOBAL TECHNOLOGIES INC. (US) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom LRBA, CD74, BMP2 PTPRB 600/4885TNKS2 2664/4885PTPN2 3245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.